Sol-Gel Technologies (SLGL) EBT Margin (QoQ) (2018 - 2026)

Sol-Gel Technologies (SLGL) EBT Margin (QoQ) (2018 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Sol-Gel Technologies 227.58 Mn 217.44 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 1.25 Mn
Dec 31, 2025 -732,383.00
Sep 30, 2025 -163,706.00
Jun 30, 2025 -81,457.00
Mar 31, 2025 2.10 Mn
Dec 31, 2024 -2.01 Mn
Sep 30, 2024 -4,534.00
Dec 31, 2023 -896,716.00
Sep 30, 2023 -186,221.00
Dec 31, 2022 -4.95 Mn
Sep 30, 2022 -140,205.00
Jun 30, 2022 1,296.00
Mar 31, 2022 -6,492.00
Dec 31, 2021 -3,009.00
Sep 30, 2021 -77,139.00
Jun 30, 2021 26,403.00
Mar 31, 2021 94,574.00
Dec 31, 2020 7,124.00
Sep 30, 2020 -108,087.00
Jun 30, 2020 46,127.00